# OnCo record claridhy (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/claridhy/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "claridhy", "NCT02989857" ;
  schema:name "ClarIDHy"@en ;
  schema:description "The first randomised trial of a targeted drug in bile duct cancer; it slowed the disease without shrinking it."@en ;
  schema:url <https://onco.cc/trials/claridhy/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02989857>, <https://api.fda.gov/drug/label.json?search=openfda.brand_name:%22TIBSOVO%22> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2017-02-20" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/>, <https://onco.cc/technologies/idh-inhibitors/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/ivosidenib/> ;
  onco:people <https://onco.cc/people/ghassan-abou-alfa/> .
